Dapagliflozin

Dapagliflozin · SGLT2 inhibitor

Type 2 diabetes, heart failure and chronic kidney disease with cardiorenal benefits

10mg tablets Once daily oral Insurance Category B

Therapeutic Areas

Metabolism

Marketed Products

Dapagliflozin

Modality

Dapagliflozin

Core Products

Tirzepatide · GIP/GLP-1 dual receptor agonist

Semaglutide · GLP-1 receptor agonist

Creating a Healthier Future Together

Explore our innovative products and pipeline, and see how Poseidon brings hope to patients worldwide